Episode Details

How AI Is Helping Diagnose Disease | Chuck Piccirillo

Season 1 Episode 17 Published 2 years, 1 month ago

Description

Technology can make healthcare more sophisticated. The harder question is whether it actually makes healthcare better for the patient.

Chuck Piccirillo, CEO of Zealic Health, joins BioTalk Unzipped to discuss patient-centered digital health, entrepreneurship, artificial intelligence, regulation, and the personal experience that helped shape his career.

Chuck shares his experience living with colitis and how it influenced his desire to improve healthcare from the patient’s perspective. He explains how Zealic Health approaches digital platforms intended to create more individualized care experiences.

The conversation then turns unexpectedly geopolitical. Chuck describes how the war in Ukraine affected his organization and how the company worked to relocate employees to Poland.

In New News, the discussion tackles the FDA’s final rule involving laboratory-developed tests and the debate surrounding regulation of LDTs as medical devices.

Gregory, Chad, and Chuck examine the difficult balance between protecting patients and creating regulatory uncertainty that may complicate innovation.

The episode closes with AI and diagnostics. Where can artificial intelligence genuinely improve medical decision-making, and where does marketing run ahead of evidence?

The larger question is not whether AI will enter healthcare. It is how healthcare can use it responsibly while keeping clinicians and patients at the center.